Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    B-cell chronic lymphocytic leukemia was added to the list of conditions in the study details. This expands the study description to include CLL cohorts.
    Difference
    0.0%
    Check dated 2026-04-02T04:55:12.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:12:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision metadata updated: v3.4.3 added and v3.4.2 removed; no substantive content on the page was changed.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:06.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the prior v3.4.1 notice about government funding lapse was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:53:13.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T06:26:05.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated several footer labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0 replacing v3.3.4). Core study information, eligibility criteria, outcomes, and study timelines remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:29:22.000Z thumbnail image

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.